Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rhythm Pharmaceuticals Inc shares valued at $3,389,756 were sold by Smith Hunter C on Jul 09 ’25. At $80.48 per share, Smith Hunter C sold 42,120 shares. The insider’s holdings dropped to 116,915 shares worth approximately $10.69 million following the completion of this transaction.
Also, Shulman Joseph sold 7,969 shares, netting a total of over 619,851 in proceeds. Following the sale of shares at $77.78 each, the insider now holds 8,509 shares.
Before that, German Christopher Paul had sold 3,817 shares from its account. In a trade valued at $308,217, the Corporate Controller & CAO traded Rhythm Pharmaceuticals Inc shares for $80.75 each. Upon closing the transaction, the insider’s holdings decreased to 3,817 shares, worth approximately $84307.68.
As published in their initiating research note from Goldman on July 10, 2025, Rhythm Pharmaceuticals Inc [RYTM] has been a Buy and the price target has been revised to $97. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early July. As of April 07, 2025, BofA Securities has increased its “Neutral” rating to a “Buy” for RYTM.
Analyzing RYTM Stock Performance
On last trading session,, Rhythm Pharmaceuticals Inc [NASDAQ: RYTM] rose 2.33% to $91.44. The stock’s lowest price that day was $88.92, but it reached a high of $92.135 in the same session. During the last five days, there has been a surge of approximately 2.74%. Over the course of the year, Rhythm Pharmaceuticals Inc shares have jumped approximately 82.81%. Shares of the company reached a 52-week high of $94.80 on 07/10/25 and a 52-week low of $45.90 on 04/07/25.
Support And Resistance Levels for Rhythm Pharmaceuticals Inc (RYTM)
According to the 24-hour chart, there is a support level at 89.53, which, if violated, would cause prices to drop to 87.62. In the upper region, resistance lies at 92.74. The next price resistance is at 94.05. RSI (Relative Strength Index) is 79.96 on the 14-day chart, showing overbought technical sentiment.
Is Rhythm Pharmaceuticals Inc subject to short interest?
Stocks of Rhythm Pharmaceuticals Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.31 million shares to 4.76 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.07 million shares. A decline of -6.59% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.22 of the overall float, the days-to-cover ratio (short ratio) decline to 8.22.
Which companies own the most shares of Rhythm Pharmaceuticals Inc (RYTM)?
In terms of Rhythm Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 95 in the next 12 months, up nearly 6.31% from the previous closing price of $89.36. Analysts anticipate Rhythm Pharmaceuticals Inc stock to reach 110 by 2025, with the lowest price target being 70. In spite of this, 5 analysts ranked Rhythm Pharmaceuticals Inc stock as Buy at the end of 2025. On January 02, 2025, Jefferies assigned a price target of “a Buy” to the stock and initiated coverage with a $80.
